The University of Chicago Header Logo

Connection

Emily Rogalski to Biomarkers

Back to Details
This is a "connection" page, showing publications Emily Rogalski has written about Biomarkers.
Emily Rogalski
Connection Strength
0.627
Biomarkers
  1. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): Framework and methodology. Alzheimers Dement. 2021 12; 17(12):2043-2055.
    View in: PubMed
    Score: 0.120
  2. Clinical and cortical decline in the aphasic variant of Alzheimer's disease. Alzheimers Dement. 2019 04; 15(4):543-552.
    View in: PubMed
    Score: 0.102
  3. Cerebrospinal fluid markers detect Alzheimer's disease in nonamnestic dementia. Alzheimers Dement. 2017 May; 13(5):598-601.
    View in: PubMed
    Score: 0.089
  4. Longitudinal neuropsychological performance of cognitive SuperAgers. J Am Geriatr Soc. 2014 Aug; 62(8):1598-600.
    View in: PubMed
    Score: 0.075
  5. Demographic, clinical, biomarker, and neuropathological correlates of posterior cortical atrophy: an international cohort study and individual participant data meta-analysis. Lancet Neurol. 2024 02; 23(2):168-177.
    View in: PubMed
    Score: 0.036
  6. The Sporadic Early-onset Alzheimer's Disease Signature Of Atrophy: Preliminary Findings From The Longitudinal Early-onset Alzheimer's Disease Study (LEADS) Cohort. Alzheimers Dement. 2023 11; 19 Suppl 9:S74-S88.
    View in: PubMed
    Score: 0.035
  7. Amyloid and tau-PET in early-onset AD: Baseline data from the Longitudinal Early-onset Alzheimer's Disease Study (LEADS). Alzheimers Dement. 2023 11; 19 Suppl 9:S98-S114.
    View in: PubMed
    Score: 0.035
  8. Sex and APOE e4 carrier effects on atrophy, amyloid PET, and tau PET burden in early-onset Alzheimer's disease. Alzheimers Dement. 2023 11; 19 Suppl 9:S49-S63.
    View in: PubMed
    Score: 0.035
  9. Cerebrospinal fluid biomarkers in the Longitudinal Early-onset Alzheimer's Disease Study. Alzheimers Dement. 2023 11; 19 Suppl 9:S115-S125.
    View in: PubMed
    Score: 0.035
  10. Assessment of executive function declines in presymptomatic and mildly symptomatic familial frontotemporal dementia: NIH-EXAMINER as a potential clinical trial endpoint. Alzheimers Dement. 2020 01; 16(1):11-21.
    View in: PubMed
    Score: 0.027
  11. A Highly Sensitive Sandwich ELISA to Detect CSF Progranulin: A Potential Biomarker for CNS Disorders. J Neuropathol Exp Neurol. 2019 05 01; 78(5):406-415.
    View in: PubMed
    Score: 0.026
  12. Alzheimer and frontotemporal pathology in subsets of primary progressive aphasia. Ann Neurol. 2008 Jun; 63(6):709-19.
    View in: PubMed
    Score: 0.012
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.